ESAB financials
$67.25−6.48%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 |
|---|---|---|---|---|
| Revenue | $2.84B | $2.74B | $2.77B | $2.59B |
| Gross profit | $1.05B | $1.04B | $1.02B | $885.5M |
| Gross margin | 36.9% | 37.9% | 36.6% | 34.1% |
| Operating income | $412.2M | $447.4M | $404.2M | $329.1M |
| Net income | $225.5M | $263.5M | $203.7M | $223.7M |
| Net margin | 7.9% | 9.6% | 7.3% | 8.6% |
| Diluted EPS | $3.67 | $4.31 | $3.36 | $3.69 |
| EBITDA | $524.0M | $524.5M | $503.3M | $418.1M |
| Operating cash flow | $260.6M | $355.4M | $330.5M | $214.4M |
| Free cash flow | $213.3M | $303.6M | $282.3M | $174.1M |
| Diluted shares | 61.3M | 61.1M | 60.7M | 60.2M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & equivalents | $185.9M | $249.4M | $102.0M | $72.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $1.23B | $1.08B | $1.02B | $1.22B |
| Total assets | $4.77B | $4.03B | $3.83B | $3.75B |
| Total liabilities | $2.55B | $2.23B | $2.18B | $2.37B |
| Shareholders' equity | $2.21B | $1.81B | $1.65B | $1.39B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology